Clinical Trials Browser

Phase 1/2 × OTHER_GOV × Lymphoma × Clear all

NCT07135466 2026-01-16

A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT02488382 2017-10-17

Lonquek for Autologous Stem Cell Mobilization

Phase 1/2 Unknown

LymphoidPlasma cell

Lymphoma, Multiple Myeloma